Sequenom Launched Cystic Fibrosis Carrier Screening Test (SQNM)
Thu. September 17, 2009; Posted: 02:57 PM
Sep 17, 2009 (SmarTrend(R) News Watch via COMTEX) --
SQNM |
Quote |
Chart |
News |
PowerRating -- 9/17/2009 - Sequenom Inc. (NASDAQ:SQNM) said Thursday it launched a genetic test, called the SensiGene Cystic Fibrosis Carrier Screening test, that determines if a person carries a mutation that can cause their children to have cystic fibrosis. The test uses Sequenom's MassARRAY platform and screens for 103 mutations and five genetic variants that are related to cystic fibrosis. The company said that roughly one in 30 Americans carries a cystic fibrosis gene mutation and that children inherit the disease when both parents have such a mutation. The American College of Medical Genetics recommends screening for 23 mutations, according to the company, but said that one in 17 carries would be missed by a scan only including those 23 mutations.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Sequenom Inc (SQNM)
click here. Sequenom Inc (SQNM) has Short Term PowerRatings of 4. Details on Sequenom Inc (SQNM) Short Term PowerRatings is available at
This Link.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index